Latest News in the pharma Industry

All

Bosch showcases new development for continuous manufacturing

Bosch showcases new development for continuous manufacturing

16 Mar 2017

The Xelum platform combines dosing, mixing, granulating and pressing, paving the way for more efficient tablet manufacturing.

Read more 
Shire receives European approval for label extension of Cinryze

Shire receives European approval for label extension of Cinryze

16 Mar 2017

Cinryze is the first and only Hereditary angioedema treatment approved for routine prevention in paediatrics.

Read more 
Optimizing development resources for efficient product development

Optimizing development resources for efficient product development

15 Mar 2017

Nowadays, efficient process research and development are, more than ever, an absolute must for contract manufacturers and API manufacturers. New products/processes need to be pushed through to market readiness faster and faster. However, development de...

Read more 
POLPHARMA B2B - VISIT US DURING DCAT WEEK MARCH 20-23, 2017 IN NEW YORK CITY

POLPHARMA B2B - VISIT US DURING DCAT WEEK MARCH 20-23, 2017 IN NEW YORK CITY

15 Mar 2017

For a quality, service and partnership-focused organization like Polpharma, responding to the growing challenges of the pharma industry partners constitutes a key focus. Therefore, during the upcoming DCAT Week in New York City, we wish to talk to our ...

Read more 
Merck's Keytruda receives FDA approval to treat patients with refractory classical Hodgkin lymphoma

Merck's Keytruda receives FDA approval to treat patients with refractory classical Hodgkin lymphoma

15 Mar 2017

Only anti-PD-1 therapy approved for the treatment of patients with difficult-to-treat cHL regardless of prior stem cell transplantation or use of brentuximab vedotin

Read more 
Metrion and Concept introduce integrated ion channel drug discovery service

Metrion and Concept introduce integrated ion channel drug discovery service

15 Mar 2017

Supports small molecule ion channel drug discovery, from initial screening to development candidate.

Read more 
$100 billion of revenues up for grabs for drug manufacturers as patents for key biologics expire

$100 billion of revenues up for grabs for drug manufacturers as patents for key biologics expire

15 Mar 2017

For success in the biosimilars sector, manufacturers must adopt QbD, DoE and PAT initiatives.

Read more 
Lallemand Health Solutions : Quality Probiotics. Complete Solutions.

Lallemand Health Solutions : Quality Probiotics. Complete Solutions.

14 Mar 2017

Read more 
Allergan and Editas Medicine all set to discover and develop CRISPR genome editing medicines for eye diseases

Allergan and Editas Medicine all set to discover and develop CRISPR genome editing medicines for eye diseases

14 Mar 2017

Alliance brings together eye care and CRISPR innovators to develop transformative medicines for patients.

Read more 
Pfizer launches new antibiotic in the UK and Germany

Pfizer launches new antibiotic in the UK and Germany

14 Mar 2017

Zavicefta treat complicated infections caused By Gram-negative bacteria.

Read more 
Colorado unapproved drug and dietary supplement makers ordered to cease operations for federal violations

Colorado unapproved drug and dietary supplement makers ordered to cease operations for federal violations

14 Mar 2017

Dietary supplement products "misbranded" and unapproved new drugs being marketed with drug claims despite not being approved for any use.

Read more 
BASF inorganic specialties divestiture creates new business named Callery

BASF inorganic specialties divestiture creates new business named Callery

14 Mar 2017

Current product portfolio includes a range of specialty alkoxide bases and borane derivatives.

Read more